🇺🇸 FDA
Patent

US 12121525

Methods for treating GI syndrome and graft versus host disease

granted A61KA61K2039/505A61K31/55

Quick answer

US patent 12121525 (Methods for treating GI syndrome and graft versus host disease) held by The Board of Regents of the University of Texas System expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K31/55, A61P, A61P1/00